NVST - Envista Holdings Corp
Close
18.26
-0.140 -0.767%
Share volume: 1,488,795
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$18.40
-0.14
-0.76%
View ratios
| Fiscal Date | 2022-07-01 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-29 | 2023-12-31 | 2024-03-29 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-03 | 2023-02-16 | 2023-05-03 | 2023-08-02 | 2023-11-01 | 2024-02-15 | 2024-05-01 | |
| Assets | |||||||||
| Total Assets | 6.461 B | 6.412 B | 6.587 B | 6.575 B | 6.607 B | 6.684 B | 6.605 B | 6.556 B | |
| Current Assets | 1.388 B | 1.366 B | 1.425 B | 1.414 B | 1.489 B | 1.641 B | 1.744 B | 1.772 B | |
| Inventories | 286.000 M | 291.300 M | 300.800 M | 307.200 M | 297.000 M | 278.800 M | 258.800 M | 267.400 M | |
| Other Current Assets | 202.300 M | 114.000 M | 123.400 M | 120.100 M | 125.000 M | 120.600 M | 137.400 M | 143.000 M | |
| Short Term Investments | 202.300 M | 114.000 M | 123.400 M | 120.100 M | 125.000 M | 120.600 M | 137.400 M | 143.000 M | |
| Total Receivables | 372.800 M | 392.200 M | 393.500 M | 401.800 M | 415.200 M | 417.100 M | 407.500 M | 413.000 M | |
| Current Cash | 523.100 M | 568.500 M | 606.900 M | 585.200 M | 651.700 M | 824.200 M | 940.000 M | 948.500 M | |
| Total Non-current Assets | 5.073 B | 5.046 B | 5.162 B | 5.161 B | 5.118 B | 5.043 B | 4.861 B | 4.784 B | |
| Property Plant Equipment | 264.100 M | 277.200 M | 293.600 M | 297.600 M | 300.100 M | 304.000 M | 309.600 M | 306.200 M | |
| Other Assets | 212.400 M | 173.200 M | 153.700 M | 158.300 M | 151.700 M | 152.900 M | 180.500 M | 174.400 M | |
| Intangible Assets | 1.076 B | 1.064 B | 1.087 B | 1.066 B | 1.043 B | 1.001 B | 954.000 M | 918.700 M | |
| Goodwill | 3.390 B | 3.400 B | 3.497 B | 3.506 B | 3.494 B | 3.458 B | 3.292 B | 3.260 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 6.461 B | 6.412 B | 6.587 B | 6.575 B | 6.607 B | 6.684 B | 6.605 B | 6.556 B | |
| Total liabilities | 2.445 B | 2.454 B | 2.380 B | 2.296 B | 2.296 B | 2.391 B | 2.431 B | 2.416 B | |
| Total current liabilities | 1.256 B | 1.258 B | 1.237 B | 1.150 B | 1.151 B | 746.800 M | 780.800 M | 781.300 M | |
| Accounts Payable | 182.700 M | 190.000 M | 228.300 M | 186.800 M | 176.800 M | 168.600 M | 179.500 M | 174.700 M | |
| Other liabilities | 201.300 M | 220.700 M | 151.300 M | 151.300 M | 153.000 M | 150.500 M | 142.400 M | 136.700 M | |
| Current long term debt | 508.600 M | 579.300 M | 510.000 M | 510.800 M | 511.500 M | 115.100 M | 115.300 M | 115.500 M | |
| Long term debt | 864.100 M | 851.600 M | 870.700 M | 873.800 M | 875.600 M | 1.381 B | 1.398 B | 1.391 B | |
| Other liabilities | 201.300 M | 220.700 M | 151.300 M | 151.300 M | 153.000 M | 150.500 M | 142.400 M | 136.700 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 4.016 B | 3.958 B | 4.207 B | 4.279 B | 4.311 B | 4.293 B | 4.174 B | 4.140 B | |
| Common stock | 162.900 M | 163.100 M | 163.400 M | 163.600 M | 164.000 M | 168.200 M | 171.800 M | 171.900 M | |
| Retained earnings | 610.300 M | 657.900 M | 731.400 M | 775.200 M | 827.100 M | 848.600 M | 631.200 M | 654.800 M |